Helicos' Q2 Revenues Rise 78 Percent as Cash Dwindles

Helicos, which is in the midst of a restructuring, saw product revenues drop by 46 percent, but grant revenues jumped 170 percent. Its cash holdings, though, stood at $3.7 million as of Aug. 11, and the firm will need additional funds to continue operations.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories